Caixin App
Newsletter
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Opinion
Weekend Long Read
Research & Analysis
Lifestyle
Books & Arts
Blog
Video
Topics
War in Ukraine
Evergrande Crisis
ESG & Carbon Goals
China-U.S. Rivalry
Coronavirus
Hobbled Huawei
Digital Currency
Fintech / Internet Finance
Selected
CX Daily
Weekly Must-Read
Energy Insider
Economic Indexes
Caixin Explains
Reg Watch
Subscriber Events
ThinkChina
Market Data
Company Index
Podcast
Highlights
Newsletter
Events
ESG
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
wang zhuoqing
Vaccine Startup Clover Biopharma Raises $230 Million in Financing
In Depth: Hundreds of Chinese Patients Died in ‘Redundant’ Trials of Proven Drugs
In Depth: Why Vaccines Won’t Soon End the Covid-19 Pandemic
coexist with the virus,” one immunologist said.
Wang
Zhuoqing
and Xiao Zhongxian contributed to this
Cover Story: Can the Virus Still Win?
said.
Wang
Zhuoqing
and Hao Tianqi contributed to this story. Contact reporter Han Wei
Sinovac Applies for Conditional Approval of Covid-19 Vaccine in China
Leading Chinese Drug Researcher Calls for Greater Transparency on China Vaccines
Chinese Vaccine Maker Seeks Approval for Broad Use of Covid-19 Inoculation
Cover Story: The Daunting Challenge of Immunizing the World
Zhihang and
Wang
Zhuoqing
contributed to this story. Contact reporter Han Wei (weihan@caixin.com
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通